As of Feb 17
| -0.02 / -0.91%|
The 5 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 1.00. The median estimate represents a -7.83% decrease from the last price of 2.17.
The current consensus among 5 polled investment analysts is to Hold stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.